跳至主要内容
临床试验/ITMCTR2100004364
ITMCTR2100004364招募中未知

Study on adjuvant therapy of adenomyosis with Xueping Tablet

Shanghai Changhai Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
28 至 48(—)
性别
Female

入选标准

  • 1. Women who meet the diagnostic criteria for adenomyosis, aged 28-48 years old, are non-menopausal and non-lactating;
  • 2. Those who voluntarily participate in this experiment and sign the informed consent.

排除标准

  • 1. Gnrh-a and steroid hormone use history within 3 months;
  • 2, levonorgestrel or iUD placement contraindications;
  • 3. Patients with cardiovascular and cerebrovascular diseases, liver, kidney, diabetes, tumor and other serious diseases;
  • 4. Mental illness patients and long-term drinking or taking drugs affect cognition;
  • 5. Patients with coagulation dysfunction or previous thrombotic diseases;
  • 6. Participating in other drug clinical subjects;
  • 7. Had a history of allergy to Traditional Chinese medicine.

研究者

相似试验